These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26441970)
41. The cardiorenal syndrome: a mutual approach to concomitant cardiac and renal failure. Ben-Shoshan J; Entin-Meer M; Guzner-Gur H; Keren G Isr Med Assoc J; 2012 Sep; 14(9):570-6. PubMed ID: 23101423 [TBL] [Abstract][Full Text] [Related]
42. Renal dysfunction and coronary disease: a high-risk combination. Schiele F J Nephrol; 2009; 22(1):39-45. PubMed ID: 19229817 [TBL] [Abstract][Full Text] [Related]
43. Cardiovascular and Renal Links along the Cardiorenal Continuum. García-Donaire JA; Ruilope LM Int J Nephrol; 2011; 2011():975782. PubMed ID: 21603119 [TBL] [Abstract][Full Text] [Related]
44. Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney disease-induced myocardial remodeling. Kundu S; Gairola S; Verma S; Mugale MN; Sahu BD Basic Res Cardiol; 2024 Oct; 119(5):831-852. PubMed ID: 38771318 [TBL] [Abstract][Full Text] [Related]
45. Role of the kisspeptin-KISS1R axis in the pathogenesis of chronic kidney disease and uremic cardiomyopathy. Dinh H; Kovács ZZA; Kis M; Kupecz K; Sejben A; Szűcs G; Márványkövi F; Siska A; Freiwan M; Pósa SP; Galla Z; Ibos KE; Bodnár É; Lauber GY; Goncalves AIA; Acar E; Kriston A; Kovács F; Horváth P; Bozsó Z; Tóth G; Földesi I; Monostori P; Cserni G; Podesser BK; Lehoczki A; Pokreisz P; Kiss A; Dux L; Csabafi K; Sárközy M Geroscience; 2024 Apr; 46(2):2463-2488. PubMed ID: 37987885 [TBL] [Abstract][Full Text] [Related]
46. Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. Junho CVC; Frisch J; Soppert J; Wollenhaupt J; Noels H Clin Kidney J; 2023 Nov; 16(11):1786-1803. PubMed ID: 37915935 [TBL] [Abstract][Full Text] [Related]
47. Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats. Sárközy M; Watzinger S; Kovács ZZA; Acar E; Márványkövi F; Szűcs G; Lauber GY; Galla Z; Siska A; Földesi I; Fintha A; Kriston A; Kovács F; Horváth P; Kővári B; Cserni G; Krenács T; Szabó PL; Szabó GT; Monostori P; Zins K; Abraham D; Csont T; Pokreisz P; Podesser BK; Kiss A JACC Basic Transl Sci; 2023 Sep; 8(9):1160-1176. PubMed ID: 37791301 [TBL] [Abstract][Full Text] [Related]
48. The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model. Dinh H; Kovács ZZA; Márványkövi F; Kis M; Kupecz K; Szűcs G; Freiwan M; Lauber GY; Acar E; Siska A; Ibos KE; Bodnár É; Kriston A; Kovács F; Horváth P; Földesi I; Cserni G; Podesser BK; Pokreisz P; Kiss A; Dux L; Csabafi K; Sárközy M Sci Rep; 2023 Aug; 13(1):14046. PubMed ID: 37640761 [TBL] [Abstract][Full Text] [Related]
49. Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease. Wang J; Lin Y; Chen X; Liu Y; Zhou T Front Cell Dev Biol; 2022; 10():910592. PubMed ID: 36268508 [TBL] [Abstract][Full Text] [Related]
51. Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy. Gutsol AA; Blanco P; Hale TM; Thibodeau JF; Holterman CE; Nasrallah R; Correa JWN; Afanasiev SA; Touyz RM; Kennedy CRJ; Burger D; Hébert RL; Burns KD PLoS One; 2022; 17(2):e0264136. PubMed ID: 35176122 [TBL] [Abstract][Full Text] [Related]
52. Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females. Sárközy M; Márványkövi FM; Szűcs G; Kovács ZZA; Szabó MR; Gáspár R; Siska A; Kővári B; Cserni G; Földesi I; Csont T Biol Sex Differ; 2021 Sep; 12(1):49. PubMed ID: 34488888 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy. Kovács ZZA; Szűcs G; Freiwan M; Kovács MG; Márványkövi FM; Dinh H; Siska A; Farkas K; Kovács F; Kriston A; Horváth P; Kővári B; Cserni BG; Cserni G; Földesi I; Csont T; Sárközy M Sci Rep; 2021 Sep; 11(1):17495. PubMed ID: 34471171 [TBL] [Abstract][Full Text] [Related]
54. Current advances of stem cell-based therapy for kidney diseases. Wong CY World J Stem Cells; 2021 Jul; 13(7):914-933. PubMed ID: 34367484 [TBL] [Abstract][Full Text] [Related]
55. Unilateral Ureteral Obstruction for 28 Days in Rats Is Not Associated with Changes in Cardiac Function or Alterations in Mitochondrial Function. Prieto-Carrasco R; Silva-Palacios A; Rojas-Morales P; Aparicio-Trejo OE; Medina-Reyes EI; Hernández-Cruz EY; Sánchez-Garibay C; Salinas-Lara C; Pavón N; Roldán FJ; Zazueta C; Tapia E; Pedraza-Chaverri J Biology (Basel); 2021 Jul; 10(7):. PubMed ID: 34356526 [TBL] [Abstract][Full Text] [Related]
56. Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model. Wesseling M; Mulder E; Brans MAD; Kapteijn DMC; Bulthuis M; Pasterkamp G; Verhaar MC; Danser AHJ; van Goor H; Joles JA; de Jager SCA Front Pharmacol; 2021; 12():614656. PubMed ID: 34211391 [TBL] [Abstract][Full Text] [Related]
57. Immunohistochemistry of Kidney a-SMA, Collagen 1, and Collagen 3, in A Novel Mouse Model of Reno-cardiac Syndrome. Kieswich JE; Chen J; Alliouachene S; Caton PW; McCafferty K; Thiemermann C; Yaqoob MM Bio Protoc; 2020 Sep; 10(18):e3751. PubMed ID: 33659410 [TBL] [Abstract][Full Text] [Related]
59. Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat. Leader CJ; Kelly DJ; Sammut IA; Wilkins GT; Walker RJ Physiol Rep; 2020 May; 8(10):e14448. PubMed ID: 32441493 [TBL] [Abstract][Full Text] [Related]